HP
48
4
VRSK
37
7
DRI
67
4
PCAR
65
4
AVGO
33
-5
COST
53
6
HPQ
25
4
EQT
48
-6
CVS
52
3
MET
50
3
SE
61
-7
AMGN
47
-2
CRM
50
-7
BXP
34
3
MHK
49
12
PCG
64
3
HST
60
3
URBN
68
4
GOOG
65
2
GE
71
-7
HP
48
4
VRSK
37
7
DRI
67
4
PCAR
65
4
AVGO
33
-5
COST
53
6
HPQ
25
4
EQT
48
-6
CVS
52
3
MET
50
3
SE
61
-7
AMGN
47
-2
CRM
50
-7
BXP
34
3
MHK
49
12
PCG
64
3
HST
60
3
URBN
68
4
GOOG
65
2
GE
71
-7
Financhill
Back

ClearShares Piton Intermediate Fixed Income ETF Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Sell
25

PIFI
ClearShares Piton Intermediate Fixed Income ETF

Last Price:
$94.81
Seasonality Move:
-1.52%
Sell
34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$53.24
Seasonality Move:
-11.9%
Sell
25
ClearShares Piton Intermediate Fixed Income ETF (PIFI) is a Sell

Is ClearShares Piton Intermediate Fixed Income ETF a Buy, Sell or Hold?

  • The current ClearShares Piton Intermediate Fixed Income ETF [PIFI] share price is $94.82. The Score for PIFI is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • PIFI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PIFI Stock Price Chart

What is ClearShares Piton Intermediate Fixed Income ETF's stock price today?

  • The ClearShares Piton Intermediate Fixed Income ETF share price today is $94.82
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PIFI is experiencing slight buying pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

PIFI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 24.07 Buy
Relative Strength Index (14 RSI): 36.98 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (95.06 - 95.64) Sell
Bollinger Bands (100): (95 - 96.1) Sell

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.28 Buy
Relative Strength Index (14 RSI): 65.68 Buy
Chaikin Money Flow: -209678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.25 - 50.15) Buy
Bollinger Bands (100): (35.32 - 47.44) Buy

PIFI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 95.1 Sell
20-day SMA: 95.32 Sell
50-day SMA: 95.31 Sell
200-day SMA: 94.97 Sell
8-day EMA: 91.41 Buy
20-day EMA: 69.26 Buy
50-day EMA: 38.62 Buy
200-day EMA: 11.61 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 48.57 Buy
50-day SMA: 45.67 Buy
200-day SMA: 36.1 Buy
8-day EMA: 49.69 Buy
20-day EMA: 48.35 Buy
50-day EMA: 45.87 Buy
200-day EMA: 40.28 Buy

ClearShares Piton Intermediate Fixed Income ETF Earnings Growth & PIFI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

ClearShares Piton Intermediate Fixed Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):